Skip Nav Destination
Issues
15 August 2010
-
Cover Image
Cover Image
Codetection of microRNA and protein markers in formalin-fixed paraffin-embedded clinical specimens. Cover image depicts expression of microRNAs and proteins in normal prostate tissue. Diffuse and apical cytoplasmic staining of cytokeratins 8 and 18 (red) as well as membranous staining of E-cadherin (blue) highlights prostatic epithelium. Cytoplasmic-enriched staining of miR-141 (green) is confined to epithelial cells, whereas that of let-7a (orange) is detected in both epithelial and stromal compartments. For further details, please see the article by Sempere and colleagues on page 4246 of this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Highlights
Editorial
CCR Translations
Molecular Pathways
Reviews
Human Cancer Biology
NF1 Inactivation in Adult Acute Myelogenous Leukemia
Brian Parkin; Peter Ouillette; Yin Wang; Yan Liu; Whitney Wright; Diane Roulston; Anjali Purkayastha; Amanda Dressel; Judith Karp; Paula Bockenstedt; Ammar Al-Zoubi; Moshe Talpaz; Lisa Kujawski; Yang Liu; Kerby Shedden; Sajid Shakhan; Cheng Li; Harry Erba; Sami N. Malek
Mutation of SDHB is a Cause of Hypoxia-Related High-Altitude Paraganglioma
Nidia Y. Cerecer-Gil; Luis E. Figuera; Francisco J. Llamas; Mauricio Lara; José G. Escamilla; Ruben Ramos; Gerardo Estrada; A. Karim Hussain; José Gaal; Esther Korpershoek; Ronald R. de Krijger; Winand N.M. Dinjens; Peter Devilee; Jean Pierre Bayley
Genomic Profiling Reveals Alternative Genetic Pathways of Meningioma Malignant Progression Dependent on the Underlying NF2 Status
Stéphane Goutagny; Hong Wei Yang; Jessica Zucman-Rossi; Jennifer Chan; Jonathan M. Dreyfuss; Peter J. Park; Peter M. Black; Marco Giovannini; Rona S. Carroll; Michel Kalamarides
Cancer Therapy: Preclinical
Gene Array and Fluorescence In situ Hybridization Biomarkers of Activity of Saracatinib (AZD0530), a Src Inhibitor, in a Preclinical Model of Colorectal Cancer
John J. Arcaroli; Basel M. Touban; Aik Choon Tan; Marileila Varella-Garcia; Rebecca W. Powell; S. Gail Eckhardt; Paul Elvin; Dexiang Gao; Wells A. Messersmith
Inhibition of Hypoxia Inducible Factor-1α by Dihydroxyphenylethanol, a Product from Olive Oil, Blocks Microsomal Prostaglandin-E Synthase-1/Vascular Endothelial Growth Factor Expression and Reduces Tumor Angiogenesis
Erika Terzuoli; Sandra Donnini; Antonio Giachetti; Miguel A. Iñiguez; Manuel Fresno; Giovanni Melillo; Marina Ziche
Imaging, Diagnosis, Prognosis
Quantitation of p95HER2 in Paraffin Sections by Using a p95-Specific Antibody and Correlation with Outcome in a Cohort of Trastuzumab-Treated Breast Cancer Patients
Jeff Sperinde; Xueguang Jin; Jayee Banerjee; Elicia Penuel; Anasuya Saha; Gundo Diedrich; Weidong Huang; Kim Leitzel; Jodi Weidler; Suhail M. Ali; Eva-Maria Fuchs; Christian F. Singer; Wolfgang J. Köstler; Michael Bates; Gordon Parry; John Winslow; Allan Lipton
Fluorescence-Based Codetection with Protein Markers Reveals Distinct Cellular Compartments for Altered MicroRNA Expression in Solid Tumors
Lorenzo F. Sempere; Meir Preis; Todd Yezefski; Haoxu Ouyang; Arief A. Suriawinata; Asli Silahtaroglu; Jose R. Conejo-Garcia; Sakari Kauppinen; Wendy Wells; Murray Korc
Genomic Alterations and Allelic Imbalances Are Strong Prognostic Predictors in Osteosarcoma
Jan Smida; Daniel Baumhoer; Michael Rosemann; Axel Walch; Stefan Bielack; Christopher Poremba; Klaus Remberger; Eberhard Korsching; Wolfram Scheurlen; Christian Dierkes; Stefan Burdach; Gernot Jundt; Michael J. Atkinson; Michaela Nathrath
MiRNA-196 Is Upregulated in Glioblastoma But Not in Anaplastic Astrocytoma and Has Prognostic Significance
Yanlei Guan; Masahiro Mizoguchi; Koji Yoshimoto; Nobuhiro Hata; Tadahisa Shono; Satoshi O. Suzuki; Yukie Araki; Daisuke Kuga; Akira Nakamizo; Toshiyuki Amano; Xinlong Ma; Kenshi Hayashi; Tomio Sasaki
Corrections
Advertisement
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds